S. 2665 · 115th Congress

A bill to require guidance on how the Food and Drug Administration will consider claims of opioid sparing and on the conditions under which the Food and Drug Administration will consider misuse and abuse of drugs in making certain determinations of safety.

Stage
In committee
Sponsor
Todd Young
Introduced
2018-04-12
Latest action
2018-04-12 · Introduced in Senate

Action history

  1. 2018-04-12Introduced in Senate
  2. 2018-04-12Read twice and referred to the Committee on Health, Education, Labor, and Pensions.